{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:46:10Z","timestamp":1792089970938,"version":"4.4.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00520-026-11156-1","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T07:41:26Z","timestamp":1788939686000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exercise and pathologic complete response to cancer treatment: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6077-2809","authenticated-orcid":false,"given":"Nuno","family":"Dias Rato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1918-6231","authenticated-orcid":false,"given":"Catarina","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4918-7190","authenticated-orcid":false,"given":"Diogo","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8346-8180","authenticated-orcid":false,"given":"Helena","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7064-9639","authenticated-orcid":false,"given":"Ana","family":"Joaquim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2224-9256","authenticated-orcid":false,"given":"Sofia","family":"Viamonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8237-2390","authenticated-orcid":false,"given":"Luisa","family":"Helguero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9147-7781","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Viana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9484-7349","authenticated-orcid":false,"given":"Alberto","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"11156_CR1","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1200\/JOP.2016.016873","volume":"12","author":"AA Wright","year":"2016","unstructured":"Wright AA, Bohlke K, Edelson MI (2016) Neoadjuvant chemotherapy for newly diagnosed advanced ovarian cancer: Society of Gynecologic Oncology and ASCO clinical practice guideline summary. J Oncol Pract 12:1254\u20131257. https:\/\/doi.org\/10.1200\/JOP.2016.016873","journal-title":"J Oncol Pract"},{"key":"11156_CR2","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1200\/JCO.20.03399","volume":"39","author":"LA Korde","year":"2021","unstructured":"Korde LA, Somerfield MR, Carey LA, Crews JR, Denduluri N, Hwang ES et al (2021) Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline. J Clin Oncol 39:1485\u20131505. https:\/\/doi.org\/10.1200\/JCO.20.03399","journal-title":"J Clin Oncol"},{"key":"11156_CR3","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1200\/JCO.24.01160","volume":"42","author":"AJ Scott","year":"2024","unstructured":"Scott AJ, Kennedy EB, Berlin J, Brown G, Chalabi M, Cho MT et al (2024) Management of locally advanced rectal cancer: ASCO guideline. J Clin Oncol 42:3355\u20133375. https:\/\/doi.org\/10.1200\/JCO.24.01160","journal-title":"J Clin Oncol"},{"key":"11156_CR4","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.hpb.2023.06.018","volume":"25","author":"I Nassour","year":"2023","unstructured":"Nassour I, Parrish A, Baptist L, Voskamp S, Handoo K, Rogers S et al (2023) National adoption of neoadjuvant chemotherapy: paradigm shift in the treatment of pancreatic cancer. HPB (Oxford) 25:1323\u20131328. https:\/\/doi.org\/10.1016\/j.hpb.2023.06.018","journal-title":"HPB (Oxford)"},{"key":"11156_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/1178223420980377","author":"M Asaoka","year":"2020","unstructured":"Asaoka M, Gandhi S, Ishikawa T, Takabe K (2020) Neoadjuvant chemotherapy for breast cancer: past, present, and future. Breast Cancer (Auckl). https:\/\/doi.org\/10.1177\/1178223420980377","journal-title":"Breast Cancer (Auckl)"},{"key":"11156_CR6","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1177\/1745505716677139","volume":"12","author":"S Masood","year":"2016","unstructured":"Masood S (2016) Neoadjuvant chemotherapy in breast cancers. Women Health (Lond) 12:480\u2013491. https:\/\/doi.org\/10.1177\/1745505716677139","journal-title":"Women Health (Lond)"},{"key":"11156_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2025.e43069","author":"M Antonini","year":"2025","unstructured":"Antonini M, Mattar A, Pereira TM, Oliveira LL, Teixeira MD, Amorim AG et al (2025) Pathologic complete response and breast cancer survival post-neoadjuvant chemotherapy: a systematic review and meta-analysis of real-world data. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2025.e43069","journal-title":"Heliyon"},{"key":"11156_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","volume":"9","author":"B Liu","year":"2024","unstructured":"Liu B, Zhou H, Tan L, Siu KTH, Guan X-Y (2024) Exploring treatment options in cancer: tumor treatment strategies. Signal Transduct Target Ther 9:175. https:\/\/doi.org\/10.1038\/s41392-024-01856-7","journal-title":"Signal Transduct Target Ther"},{"key":"11156_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13112770","volume":"13","author":"DY Chung","year":"2021","unstructured":"Chung DY, Kang DH, Kim JW, Ha JS, Kim DK, Cho KS (2021) Comparison of oncologic outcomes of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) with gemcitabine and cisplatin (GC) as neoadjuvant chemotherapy for muscle-invasive bladder cancer: systematic review and meta-analysis. Cancers (Basel) 13:2770. https:\/\/doi.org\/10.3390\/cancers13112770","journal-title":"Cancers (Basel)"},{"key":"11156_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2022.100384","volume":"3","author":"S Rosner","year":"2022","unstructured":"Rosner S, Liu C, Forde PM, Hu C (2022) Association of pathologic complete response and long-term survival outcomes among patients treated with neoadjuvant chemotherapy or chemoradiotherapy for NSCLC: a meta-analysis. JTO Clin Res Rep 3:100384. https:\/\/doi.org\/10.1016\/j.jtocrr.2022.100384","journal-title":"JTO Clin Res Rep"},{"key":"11156_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17020163","volume":"17","author":"C Y\u0131lmaz","year":"2025","unstructured":"Y\u0131lmaz C, Zengel B, \u00dcreyen O, Ad\u0131belli ZH, Ta\u015fl\u0131 F, Y\u0131lmaz HT et al (2025) A comprehensive analysis of neoadjuvant chemotherapy in breast cancer: adverse events, clinical response rates, and surgical and pathological outcomes\u2014Bozyaka experience. Cancers (Basel) 17:163. https:\/\/doi.org\/10.3390\/cancers17020163","journal-title":"Cancers (Basel)"},{"key":"11156_CR12","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1177\/0003134820972083","volume":"87","author":"C Kaltenmeier","year":"2021","unstructured":"Kaltenmeier C, Althans A, Mascara M, Nassour I, Khan S, Hoehn R et al (2021) Pathologic complete response following neoadjuvant therapy for gastric adenocarcinoma: a National Cancer Database analysis on incidence, predictors, and outcomes. Am Surg 87:1145\u20131154. https:\/\/doi.org\/10.1177\/0003134820972083","journal-title":"Am Surg"},{"key":"11156_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong X, Zheng L-W, Ding Y, Chen Y-F, Cai Y-W, Wang L-P et al (2025) Breast cancer: pathogenesis and treatments. Signal Transduct Target Ther 10:49. https:\/\/doi.org\/10.1038\/s41392-024-02108-4","journal-title":"Signal Transduct Target Ther"},{"key":"11156_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1093\/annonc\/mdx773","volume":"29","author":"SM Swain","year":"2018","unstructured":"Swain SM, Ewer MS, Viale G, Delaloge S, Ferrero J-M, Verrill M et al (2018) Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study. Ann Oncol 29:646\u2013653. https:\/\/doi.org\/10.1093\/annonc\/mdx773","journal-title":"Ann Oncol"},{"key":"11156_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s44276-024-00064-8","volume":"2","author":"R Juthani","year":"2024","unstructured":"Juthani R, Punatar S, Mittra I (2024) New light on chemotherapy toxicity and its prevention. BJC Rep 2:41. https:\/\/doi.org\/10.1038\/s44276-024-00064-8","journal-title":"BJC Rep"},{"key":"11156_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/epirev\/mxx007","volume":"39","author":"P Cormie","year":"2017","unstructured":"Cormie P, Zopf EM, Zhang X, Schmitz KH (2017) The impact of exercise on cancer mortality, recurrence, and treatment-related adverse effects. Epidemiol Rev 39:71\u201392. https:\/\/doi.org\/10.1093\/epirev\/mxx007","journal-title":"Epidemiol Rev"},{"key":"11156_CR17","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0000000000002116","author":"KL Campbell","year":"2019","unstructured":"Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS et al (2019) Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. https:\/\/doi.org\/10.1249\/MSS.0000000000002116","journal-title":"Med Sci Sports Exerc"},{"key":"11156_CR18","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1200\/JCO.22.00687","volume":"40","author":"JA Ligibel","year":"2022","unstructured":"Ligibel JA, Bohlke K, May AM, Clinton SK, Demark-Wahnefried W, Gilchrist SC et al (2022) Exercise, diet, and weight management during cancer treatment: ASCO guideline. J Clin Oncol 40:2491\u20132507. https:\/\/doi.org\/10.1200\/JCO.22.00687","journal-title":"J Clin Oncol"},{"key":"11156_CR19","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0000000000001937","author":"A Mctiernan","year":"2019","unstructured":"Mctiernan A, Friedenreich CM, Katzmarzyk PT, Powell KE, Macko R, Buchner D et al (2019) Physical activity in cancer prevention and survival: a systematic review. Med Sci Sports Exerc. https:\/\/doi.org\/10.1249\/MSS.0000000000001937","journal-title":"Med Sci Sports Exerc"},{"key":"11156_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa2502760","volume":"393","author":"KS Courneya","year":"2025","unstructured":"Courneya KS, Vardy JL, O\u2019Callaghan CJ, Gill S, Friedenreich CM, Wong RKS et al (2025) Structured exercise after adjuvant chemotherapy for colon cancer. N Engl J Med 393:13\u201325. https:\/\/doi.org\/10.1056\/NEJMoa2502760","journal-title":"N Engl J Med"},{"key":"11156_CR21","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.1158\/0008-5472.CAN-21-1258","volume":"81","author":"L Yang","year":"2021","unstructured":"Yang L, Morielli AR, Heer E, Kirkham AA, Cheung WY, Usmani N et al (2021) Effects of exercise on cancer treatment efficacy: a systematic review of preclinical and clinical studies. Cancer Res 81:4889\u20134895. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-1258","journal-title":"Cancer Res"},{"key":"11156_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00035","author":"R-C-R Eschke","year":"2019","unstructured":"Eschke R-C-R, Lampit A, Schenk A, Javelle F, Steindorf K, Diel P et al (2019) Impact of physical exercise on growth and progression of cancer in rodents\u2014a systematic review and meta-analysis. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2019.00035","journal-title":"Front Oncol"},{"key":"11156_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jshs.2025.101063","volume":"14","author":"CJ Rayner","year":"2025","unstructured":"Rayner CJ, Bartlett DB, Allen SK, Wooldridge T, Seymour T, Sunshine S et al (2025) Prehabilitation during neoadjuvant chemotherapy results in an enhanced immune response in esophageal adenocarcinoma tumors: a randomized controlled trial. J Sport Health Sci 14:101063. https:\/\/doi.org\/10.1016\/j.jshs.2025.101063","journal-title":"J Sport Health Sci"},{"key":"11156_CR24","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/jamaoncol.2024.2156","volume":"10","author":"LW Jones","year":"2024","unstructured":"Jones LW, Moskowitz CS, Lee CP, Fickera GA, Chun SS, Michalski MG et al (2024) Neoadjuvant exercise therapy in prostate cancer. JAMA Oncol 10:1187. https:\/\/doi.org\/10.1001\/jamaoncol.2024.2156","journal-title":"JAMA Oncol"},{"key":"11156_CR25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.clcc.2021.05.004","volume":"20","author":"AR Morielli","year":"2021","unstructured":"Morielli AR, Usmani N, Boul\u00e9 NG, Severin D, Tankel K, Joseph K et al (2021) Feasibility, safety, and preliminary efficacy of exercise during and after neoadjuvant rectal cancer treatment: a phase II randomized controlled trial. Clin Colorectal Cancer 20:216\u2013226. https:\/\/doi.org\/10.1016\/j.clcc.2021.05.004","journal-title":"Clin Colorectal Cancer"},{"key":"11156_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13102-022-00420-6","volume":"14","author":"KM Sturgeon","year":"2022","unstructured":"Sturgeon KM, Smith AM, Federici EH, Kodali N, Kessler R, Wyluda E et al (2022) Feasibility of a tailored home-based exercise intervention during neoadjuvant chemotherapy in breast cancer patients. BMC Sports Sci Med Rehabil 14:31. https:\/\/doi.org\/10.1186\/s13102-022-00420-6","journal-title":"BMC Sports Sci Med Rehabil"},{"key":"11156_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1136\/bjsports-2021-104243","volume":"56","author":"J Zylstra","year":"2022","unstructured":"Zylstra J, Whyte GP, Beckmann K, Pate J, Santaolalla A, Gervais-Andre L et al (2022) Exercise prehabilitation during neoadjuvant chemotherapy may enhance tumour regression in oesophageal cancer: results from a prospective non-randomised trial. Br J Sports Med 56:402\u2013409. https:\/\/doi.org\/10.1136\/bjsports-2021-104243","journal-title":"Br J Sports Med"},{"key":"11156_CR28","doi-asserted-by":"publisher","first-page":"5285","DOI":"10.1200\/JCO.23.00871","volume":"41","author":"T Sanft","year":"2023","unstructured":"Sanft T, Harrigan M, McGowan C, Cartmel B, Zupa M, Li F-Y et al (2023) Randomized trial of exercise and nutrition on chemotherapy completion and pathologic complete response in women with breast cancer: the lifestyle, exercise, and nutrition early after diagnosis study. J Clin Oncol 41:5285\u20135295. https:\/\/doi.org\/10.1200\/JCO.23.00871","journal-title":"J Clin Oncol"},{"key":"11156_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-024-08942-0","volume":"32","author":"H Guedes","year":"2024","unstructured":"Guedes H, Jo\u00e3o D, Caldas M, Antunes P, Costa T, Alves A et al (2024) Exploring the effect of exercise training on breast cancer\u2019s pathologic response and tumor immune microenvironment after neoadjuvant chemotherapy. Support Care Cancer 32:739. https:\/\/doi.org\/10.1007\/s00520-024-08942-0","journal-title":"Support Care Cancer"},{"key":"11156_CR30","doi-asserted-by":"publisher","first-page":"6632","DOI":"10.1097\/JS9.0000000000001663","volume":"110","author":"L Loughney","year":"2024","unstructured":"Loughney L, Bolger J, Tully R, Sorensen J, Bambrick M, Carroll PA et al (2024) The effect of a pre-operative and post-operative exercise programme versus standard care on physical fitness of patients with oesophageal and gastric cancer undergoing neoadjuvant treatment prior to surgery (the PERIOP-OG trial): a randomized controlled trial. Int J Surg 110:6632\u20136646. https:\/\/doi.org\/10.1097\/JS9.0000000000001663","journal-title":"Int J Surg"},{"key":"11156_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35575","author":"NM Iyengar","year":"2025","unstructured":"Iyengar NM, Scott JM, Lee J, Lavery JA, Foug KL, Lee CP et al (2025) Effects of exercise therapy on chemotherapy delivery and response in primary breast cancer: a secondary analysis of a randomized trial. Cancer. https:\/\/doi.org\/10.1002\/cncr.35575","journal-title":"Cancer"},{"key":"11156_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101937","author":"SN Thomsen","year":"2023","unstructured":"Thomsen SN, Lahart IM, Thomsen LM, Fridh MK, Larsen A, Mau-S\u00f8rensen M et al (2023) Harms of exercise training in patients with cancer undergoing systemic treatment: a systematic review and meta-analysis of published and unpublished controlled trials. EClinicalMedicine. https:\/\/doi.org\/10.1016\/j.eclinm.2023.101937","journal-title":"EClinicalMedicine"},{"key":"11156_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2020) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"11156_CR34","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1200\/JCO.23.00435","volume":"41","author":"JK Litton","year":"2023","unstructured":"Litton JK, Regan MM, Pusztai L, Rugo HS, Tolaney SM, Garrett-Mayer E et al (2023) Standardized definitions for efficacy end points in neoadjuvant breast cancer clinical trials: NeoSTEEP. J Clin Oncol 41:4433\u20134442. https:\/\/doi.org\/10.1200\/JCO.23.00435","journal-title":"J Clin Oncol"},{"key":"11156_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-025-03594-8","volume":"25","author":"Y Chen","year":"2025","unstructured":"Chen Y, He J, Zheng J, Lin Y, Wang H, Lian L et al (2025) Impact of pathological complete response on survival in gastric cancer after neoadjuvant chemotherapy: a propensity score matching analysis. BMC Gastroenterol 25:11. https:\/\/doi.org\/10.1186\/s12876-025-03594-8","journal-title":"BMC Gastroenterol"},{"key":"11156_CR36","unstructured":"Caspersen CJ, Powell KE, Christenson GM (1985) Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep 100:126-31."},{"key":"11156_CR37","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1158\/1078-0432.CCR-15-1961","volume":"22","author":"SA Funt","year":"2016","unstructured":"Funt SA, Chapman PB (2016) The Role of Neoadjuvant Trials in Drug Development for Solid Tumors. Clin Cancer Res 22:2323\u20132328. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-1961","journal-title":"Clin Cancer Res"},{"key":"11156_CR38","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12874-022-01631-8","volume":"22","author":"A Valizadeh","year":"2022","unstructured":"Valizadeh A, Moassefi M, Nakhostin-Ansari A, Hosseini Asl SH, Saghab Torbati M, Aghajani R et al (2022) Abstract screening using the automated tool Rayyan: results of effectiveness in three diagnostic test accuracy systematic reviews. BMC Med Res Methodol 22:160. https:\/\/doi.org\/10.1186\/s12874-022-01631-8","journal-title":"BMC Med Res Methodol"},{"key":"11156_CR39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12874-021-01451-2","volume":"21","author":"C Hamel","year":"2021","unstructured":"Hamel C, Hersi M, Kelly SE, Tricco AC, Straus S, Wells G et al (2021) Guidance for using artificial intelligence for title and abstract screening while conducting knowledge syntheses. BMC Med Res Methodol 21:285. https:\/\/doi.org\/10.1186\/s12874-021-01451-2","journal-title":"BMC Med Res Methodol"},{"key":"11156_CR40","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/bmjebm-2022-112102","volume":"28","author":"E Flemyng","year":"2023","unstructured":"Flemyng E, Moore TH, Boutron I, Higgins JP, Hr\u00f3bjartsson A, Nejstgaard CH et al (2023) Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane. BMJ Evid Based Med 28:260\u2013266. https:\/\/doi.org\/10.1136\/bmjebm-2022-112102","journal-title":"BMJ Evid Based Med"},{"key":"11156_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/XEB.0000000000000020","volume":"13","author":"NA Smart","year":"2015","unstructured":"Smart NA, Waldron M, Ismail H, Giallauria F, Vigorito C, Cornelissen V et al (2015) Validation of a new tool for the assessment of study quality and reporting in exercise training studies. Int J Evid Based Healthc 13:9\u201318. https:\/\/doi.org\/10.1097\/XEB.0000000000000020","journal-title":"Int J Evid Based Healthc"},{"key":"11156_CR42","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924\u2013926. https:\/\/doi.org\/10.1136\/bmj.39489.470347.AD","journal-title":"BMJ"},{"key":"11156_CR43","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/XEB.0000000000000141","volume":"16","author":"L Furuya-Kanamori","year":"2018","unstructured":"Furuya-Kanamori L, Barendregt JJ, Doi SAR (2018) A new improved graphical and quantitative method for detecting bias in meta-analysis. Int J Evid Based Healthc 16:195\u2013203. https:\/\/doi.org\/10.1097\/XEB.0000000000000141","journal-title":"Int J Evid Based Healthc"},{"key":"11156_CR44","doi-asserted-by":"publisher","unstructured":"Mast IH, Gootjes EC, R\u00fctten H, den Hartogh MD, Brouwer CG, Nagtegaal ID, et al. (2025) Feasibility and clinical potential of exercise interventions during neoadjuvant chemoradiotherapy in patients with esophageal and rectal cancer. J Sport Health Sci 14:101060. https:\/\/doi.org\/10.1016\/j.jshs.2025.101060","DOI":"10.1016\/j.jshs.2025.101060"},{"key":"11156_CR45","doi-asserted-by":"publisher","unstructured":"Schmidt ME, Goldschmidt S, Kreutz C, M\u00fcller J, Schneeweiss A, May AM, et al. (2025) Effects of aerobic or resistance exercise during neoadjuvant chemotherapy on tumor response and therapy completion in women with breast cancer: The randomized controlled BENEFIT trial. J Sport Health Sci 14:101064. https:\/\/doi.org\/10.1016\/j.jshs.2025.101064","DOI":"10.1016\/j.jshs.2025.101064"},{"key":"11156_CR46","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1055\/s-0044-101149","volume":"39","author":"A Figueira","year":"2018","unstructured":"Figueira A, Cortinhas A, Soares J, Leit\u00e3o J, Ferreira R, Duarte J (2018) Efficacy of exercise on breast cancer outcomes: a systematic review and meta-analysis of preclinical data. Int J Sports Med 39:327\u2013342. https:\/\/doi.org\/10.1055\/s-0044-101149","journal-title":"Int J Sports Med"},{"key":"11156_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.843810","author":"Y Li","year":"2022","unstructured":"Li Y, Xiao X, Zhang Y, Tang W, Zhong D, Liu T et al (2022) Effect of exercise on breast cancer: a systematic review and meta-analysis of animal experiments. Front Mol Biosci. https:\/\/doi.org\/10.3389\/fmolb.2022.843810","journal-title":"Front Mol Biosci"},{"key":"11156_CR48","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.cmet.2016.01.011","volume":"23","author":"L Pedersen","year":"2016","unstructured":"Pedersen L, Idorn M, Olofsson GH, Lauenborg B, Nookaew I, Hansen RH et al (2016) Voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent NK cell mobilization and redistribution. Cell Metab 23:554\u2013562. https:\/\/doi.org\/10.1016\/j.cmet.2016.01.011","journal-title":"Cell Metab"},{"key":"11156_CR49","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.59996","author":"H Rundqvist","year":"2020","unstructured":"Rundqvist H, Veli\u00e7a P, Barbieri L, Gameiro PA, Bargiela D, Gojkovic M et al (2020) Cytotoxic T-cells mediate exercise-induced reductions in tumor growth. Elife. https:\/\/doi.org\/10.7554\/eLife.59996","journal-title":"Elife"},{"key":"11156_CR50","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14635","author":"ST Orange","year":"2020","unstructured":"Orange ST, Jordan AR, Saxton JM (2020) The serological responses to acute exercise in humans reduce cancer cell growth in vitro: a systematic review and meta-analysis. Physiol Rep. https:\/\/doi.org\/10.14814\/phy2.14635","journal-title":"Physiol Rep"},{"key":"11156_CR51","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.cell.2017.11.009","volume":"171","author":"AC Palmer","year":"2017","unstructured":"Palmer AC, Sorger PK (2017) Combination cancer therapy can confer benefit via patient-to-patient variability without drug additivity or synergy. Cell 171:1678-1691.e13. https:\/\/doi.org\/10.1016\/j.cell.2017.11.009","journal-title":"Cell"},{"key":"11156_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15194689","volume":"15","author":"P Miziak","year":"2023","unstructured":"Miziak P, Baran M, B\u0142aszczak E, Przybyszewska-Podstawka A, Ka\u0142afut J, Smok-Kalwat J et al (2023) Estrogen receptor signaling in breast cancer. Cancers (Basel) 15:4689. https:\/\/doi.org\/10.3390\/cancers15194689","journal-title":"Cancers (Basel)"},{"key":"11156_CR53","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-21-0437","volume":"31","author":"CTV Swain","year":"2022","unstructured":"Swain CTV, Drummond AE, Boing L, Milne RL, English DR, Brown KA et al (2022) Linking physical activity to breast cancer via sex hormones, part 1: the effect of physical activity on sex steroid hormones. Cancer Epidemiol Biomarkers Prev 31:16\u201327. https:\/\/doi.org\/10.1158\/1055-9965.EPI-21-0437","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"11156_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14010206","volume":"14","author":"CK Maharjan","year":"2021","unstructured":"Maharjan CK, Mo J, Wang L, Kim M-C, Wang S, Borcherding N et al (2021) Natural and synthetic estrogens in chronic inflammation and breast cancer. Cancers (Basel) 14:206. https:\/\/doi.org\/10.3390\/cancers14010206","journal-title":"Cancers (Basel)"},{"key":"11156_CR55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cmet.2017.09.015","volume":"27","author":"P Hojman","year":"2018","unstructured":"Hojman P, Gehl J, Christensen JF, Pedersen BK (2018) Molecular mechanisms linking exercise to cancer prevention and treatment. Cell Metab 27:10\u201321. https:\/\/doi.org\/10.1016\/j.cmet.2017.09.015","journal-title":"Cell Metab"},{"key":"11156_CR56","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1177\/1559827610361565","volume":"4","author":"TL Lenz","year":"2010","unstructured":"Lenz TL (2010) Pharmacokinetic drug interactions with physical activity. Am J Lifestyle Med 4:226\u2013229. https:\/\/doi.org\/10.1177\/1559827610361565","journal-title":"Am J Lifestyle Med"},{"key":"11156_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1474770","author":"Y Feng","year":"2024","unstructured":"Feng Y, Feng X, Wan R, Luo Z, Qu L, Wang Q (2024) Impact of exercise on cancer: mechanistic perspectives and new insights. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1474770","journal-title":"Front Immunol"},{"key":"11156_CR58","doi-asserted-by":"publisher","DOI":"10.1177\/1534735420946834","author":"A-S Mazzoni","year":"2020","unstructured":"Mazzoni A-S, Brooke HL, Berntsen S, Nordin K, Demmelmaier I (2020) Exercise adherence and effect of self-regulatory behavior change techniques in patients undergoing curative cancer treatment: secondary analysis from the Phys-Can randomized controlled trial. Integr Cancer Ther. https:\/\/doi.org\/10.1177\/1534735420946834","journal-title":"Integr Cancer Ther"},{"key":"11156_CR59","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1249\/MSS.0b013e3182a038b9","volume":"46","author":"FL Miller","year":"2014","unstructured":"Miller FL, O\u2019Connor DP, Herring MP, Sailors MH, Jackson AS, Dishman RK et al (2014) Exercise dose, exercise adherence, and associated health outcomes in the TIGER study. Med Sci Sports Exerc 46:69\u201375. https:\/\/doi.org\/10.1249\/MSS.0b013e3182a038b9","journal-title":"Med Sci Sports Exerc"},{"key":"11156_CR60","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1136\/bjsports-2022-105669","volume":"57","author":"L Garcia","year":"2023","unstructured":"Garcia L, Pearce M, Abbas A, Mok A, Strain T, Ali S et al (2023) Non-occupational physical activity and risk of cardiovascular disease, cancer and mortality outcomes: a dose\u2013response meta-analysis of large prospective studies. Br J Sports Med 57:979\u2013989. https:\/\/doi.org\/10.1136\/bjsports-2022-105669","journal-title":"Br J Sports Med"},{"key":"11156_CR61","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ctrv.2016.11.010","volume":"52","author":"LM Buffart","year":"2017","unstructured":"Buffart LM, Kalter J, Sweegers MG, Courneya KS, Newton RU, Aaronson NK et al (2017) Effects and moderators of exercise on quality of life and physical function in patients with cancer: an individual patient data meta-analysis of 34 RCTs. Cancer Treat Rev 52:91\u2013104. https:\/\/doi.org\/10.1016\/j.ctrv.2016.11.010","journal-title":"Cancer Treat Rev"},{"key":"11156_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143428","volume":"14","author":"G Reverte-Pagola","year":"2022","unstructured":"Reverte-Pagola G, S\u00e1nchez-Trigo H, Saxton J, Sa\u00f1udo B (2022) Supervised and non-supervised exercise programs for the management of cancer-related fatigue in women with breast cancer: a systematic review and meta-analysis. Cancers (Basel) 14:3428. https:\/\/doi.org\/10.3390\/cancers14143428","journal-title":"Cancers (Basel)"},{"key":"11156_CR63","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.mayocpiqo.2024.01.004","volume":"8","author":"R Sharman","year":"2024","unstructured":"Sharman R, Harris Z, Ernst B, Mussallem D, Larsen A, Gowin K (2024) Lifestyle Factors and Cancer: A Narrative Review. Mayo Clin Proc Innov Qual Outcomes 8:166\u2013183. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2024.01.004","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"11156_CR64","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/s41416-020-0741-x","volume":"122","author":"Y-B Zhang","year":"2020","unstructured":"Zhang Y-B, Pan X-F, Chen J, Cao A, Zhang Y-G, Xia L et al (2020) Combined lifestyle factors, incident cancer, and cancer mortality: a systematic review and meta-analysis of prospective cohort studies. Br J Cancer 122:1085\u20131093. https:\/\/doi.org\/10.1038\/s41416-020-0741-x","journal-title":"Br J Cancer"},{"key":"11156_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/nu14102110","volume":"14","author":"O Barnes","year":"2022","unstructured":"Barnes O, Wilson RL, Gonzalo-Encabo P, Kang D-W, Christopher CN, Bentley T et al (2022) The effect of exercise and nutritional interventions on body composition in patients with advanced or metastatic cancer: a systematic review. Nutrients 14:2110. https:\/\/doi.org\/10.3390\/nu14102110","journal-title":"Nutrients"},{"key":"11156_CR66","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.advnut.2022.10.001","volume":"14","author":"M Khalafi","year":"2023","unstructured":"Khalafi M, Hossein Sakhaei M, Kheradmand S, Symonds ME, Rosenkranz SK (2023) The impact of exercise and dietary interventions on circulating leptin and adiponectin in individuals who are overweight and those with obesity: A systematic review and meta-analysis. Adv Nutr 14:128\u2013146. https:\/\/doi.org\/10.1016\/j.advnut.2022.10.001","journal-title":"Adv Nutr"},{"key":"11156_CR67","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1007\/s11764-023-01396-z","volume":"18","author":"X Liu","year":"2024","unstructured":"Liu X, Xu X, Cheung DST, Chau PH, Ho M-H, Takemura N et al (2024) The effects of exercise with or without dietary advice on muscle mass, muscle strength, and physical functioning among older cancer survivors: a meta-analysis of randomized controlled trials. J Cancer Surviv 18:1548\u20131556. https:\/\/doi.org\/10.1007\/s11764-023-01396-z","journal-title":"J Cancer Surviv"},{"key":"11156_CR68","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jsams.2023.08.178","volume":"26","author":"C Malveiro","year":"2023","unstructured":"Malveiro C, Correia IR, Cargaleiro C, Magalh\u00e3es JP, de Matos LV, Hil\u00e1rio S et al (2023) Effects of exercise training on cancer patients undergoing neoadjuvant treatment: a systematic review. J Sci Med Sport 26:586\u2013592. https:\/\/doi.org\/10.1016\/j.jsams.2023.08.178","journal-title":"J Sci Med Sport"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11156-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11156-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11156-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:47:45Z","timestamp":1792086465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11156-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":68,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11156"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11156-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"948"}}